Taiwan FDA registration 4a7adc98bb5a1ce358b677a94fe174ed
Trinity biotechnical anomalies, coagulation control plasma
TW: 崔尼蒂生技異常值凝血對照血漿
Taiwan·Risk Class 2·TRINITY BIOTECH PLC·Registered Feb 05, 2007 – Feb 05, 2012CancelledRegistration details
- Analysis ID
- 4a7adc98bb5a1ce358b677a94fe174ed
- Customs Code
- DHA00601790001
Company information
- Manufacturer
- TRINITY BIOTECH PLC
- Manufacturer Country
- Ireland
- Authorized Representative
- BioChain Co., Ltd.
Product details
- Intended Use
- 做為前凝血酵素時間(PT)及部份血栓形成素時間(APTT)與纖維蛋白質(Fibrinogen determination)異常值對照液.
- Product Type (Level 1)
- B Hematology, pathology, and genetics
- Product Type (Level 2)
- B.5425 Versatile system for in vitro agglutination studies
- Import Information
- import
Dates and status
- Registration Date
- Feb 05, 2007
- Expiry Date
- Feb 05, 2012
- Cancellation Date
- Apr 30, 2014
Cancellation information
- Status
- Logged out
- Reason
- 許可證已逾有效期
About this record
Access comprehensive regulatory information for Trinity biotechnical anomalies, coagulation control plasma in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 4a7adc98bb5a1ce358b677a94fe174ed and manufactured by TRINITY BIOTECH PLC. The authorized representative in Taiwan is BioChain Co., Ltd..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices